Avenir
Device Hips
PDI 00889024512405
General payments
$14,030,059
Research payments
$248,060
Through program year 2025, $14,030,059 in general payments and $248,060 in research payments were reported against Avenir (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,937,398 | 2,369 |
| 2025 | Research | $39,919 | 14 |
| 2024 | General | $6,667,869 | 2,709 |
| 2024 | Research | $25,508 | 10 |
| 2023 | General | $2,354,247 | 1,970 |
| 2023 | Research | $56,650 | 12 |
| 2022 | General | $2,070,544 | 2,311 |
| 2022 | Research | $125,983 | 19 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,359 general · 55 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.